全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...
药学学报  2013 

碳酸酐酶ix小分子抑制剂的研究进展

, PP. 1637-1643

Keywords: 碳酸酐酶ix,抑制剂,缺氧,抗肿瘤

Full-Text   Cite this paper   Add to My Lib

Abstract:

碳酸酐酶ix(caix)是一个肿瘤相关蛋白,由于其在多种肿瘤组织中高度表达而在正常组织中几乎不表达,近年来成为一个潜在的抗癌靶点。寻找能够选择性抑制caix的小分子抑制剂将成为未来的焦点。本文对其在肿瘤生理活动中的作用、三维晶体结构的特征及小分子抑制剂研究进展进行综述。

References

[1]  krishnamurthyvm,kaufmangk,urbachar,etal.carbonicanhydraseasamodelforbiophysicalandphysical-organicstudiesofproteinsandprotein-ligandbinding[j].chemrev,2008,108:946-1051.
[2]  swietachp,hulikovaa,vaughan-jonesrd,etal.newinsightsintothephysiologicalroleofcarbonicanhydraseixintumourphregulation[j].oncogene,2010,29:6509-6521.
[3]  chichej,brahimi-hornmc,pouysségurj.tumourhypoxiainducesametabolicshiftcausingacidosis:acommonfeatureincancer[j].jcellmolmed,2010,14:771-794.
[4]  brahimi-hornmc,pouysségurj.hypoxiaincancercellmetabolismandphregulation[j].essaysbiochem,2007,43:165-178.
[5]  nerid,supuranct.interferingwithphregulationintumoursasatherapeuticstrategy[j].natrevdrugdiscov,2011,10:767-777.
[6]  alteriov,hilvom,difiorea,etal.crystalstructureofthecatalyticdomainofthetumor-associatedhumancarbonicanhydraseix[j].procnatlacadsciusa,2009,106:16233-16238.
[7]  montism,supuranct,desimoneg.carbonicanhydraseixasatargetfordesigningnovelanticancerdrugs[j].currmedchem,2012,19:821-830.
[8]  alteriov,vitalerm,montism,etal.carbonicanhydraseinhibitors:x-rayandmolecularmodelingstudyfortheinteractionofafluorescentantitumorsulfonamidewithisozymeⅱandix[j].jamchemsoc,2006,128:8329-8335.
[9]  thirya,ledecqm,cecchia,etal.indanesulfonamidesascarbonicanhydraseinhibitors:towardstructure-baseddesignofselectiveinhibitorsofthetumor-associatedisozymecaix[j].jmedchem,2006,49:2743-2749.
[10]  alafeefyam,isiks,abdel-azizha,etal.carbonicanhydraseinhibitors:benzenesulfonamidesincorporatingcyanoacrylamidemoietiesarelownanomolar/subnanomolarinhibitorsofthetumor-associatedisoformsixandxii[j].bioorgmedchem,2013,21:1396-1403.
[11]  gittor,damianofm,maderp,etal.synthesis,structure-activityrelationshipstudies,andx-raycrystallographicanalysisofarylsulfonamidesaspotentcarbonicanhydraseinhibitors[j].jmedchem,2012,55:3891-3899.
[12]  cand,spinglerb,schmutzp,etal.[(cp-r)m(co)3](m=reor99mtc)arylsulfonamide,arylsulfamide,andarylsulfamateconjugatesforselectivetargetingofhumancarbonicanhydraseix[j].angewchemintedengl,2012,51:3354-3357.
[13]  gielingrg,baburm,mamnanil,etal.antimetastaticeffectofsulfamatecarbonicanhydraseixinhibitorsinbreastcarcinomaxenografts[j].jmedchem,2012,55:5591-5600.
[14]  winumjy,marescaa,cartaf,etal.polypharmacologyofsulfonamides:pazopanib,amultitargetedreceptortyrosinekinaseinhibitorinclinicaluse,potentlyinhibitsseveralmammaliancarbonicanhydrases[j].chemcommun(camb),2012,48:8177-8179.
[15]  thirya,ledecqm,cecchia,etal.ligand-basedandstructure-basedvirtualscreeningtoidentifycarbonicanhydraseixinhibitors[j].bioorgmedchem,2009,17:553-557.
[16]  thirya,delayena,goossensl,etal.synthesisandbiologicalevaluationofanewfamilyofanti-benzylanilinosulfonamidesascaixinhibitors[j].eurjmedchem,2009,44:511-518.
[17]  vitalerm,alteriov,innocentia,etal.carbonicanhydraseinhibitors.comparisonofaliphaticsulfamate/bis-sulfamateadductswithisozymesⅱandixasaplatformfordesigningtight-binding,moreisoform-selectiveinhibitors[j].jmedchem,2009,52:5990-5998.
[18]  lucl,zhoul,lizc,etal.pharmacophoremodeling,virtualscreening,andmoleculardockingstudiesfordiscoveryofnovelcarbonicanhydraseixinhibitors[j].medchemres,2012,21:3417-3427.
[19]  touisnin,marescaa,mcdonaldpc,etal.glycosylcoumarincarbonicanhydraseixandxiiinhibitorsstronglyattenuatethegrowthofprimarybreasttumors[j].jmedchem,2011,54:8271-8277.
[20]  supuranct.carbonicanhydrases:noveltherapeuticapplicationsforinhibitorsandactivators[j].natrevdrugdiscov,2008,7:168-181.
[21]  kimsj,rabbanizn,vollmerrt,etal.carbonicanhydraseixinearly-stagenon-smallcelllungcancer[j].clincancerres,2004,l0:7925-7933.
[22]  shuringv,shurinmr,bykovskaias,etal.neuroblastoma-derivedgangliosidesinhibitdendriticcellgenerationandfunction[j].cancerres,2001,61:363-369.
[23]  svastováe,hulíkováa,rafajovám,etal.hypoxiaactivatesthecapacityoftumor-associatedcarbonicanhydraseixtoacidifyextracellularph[j].febslett,2004,577:439-445.
[24]  morganpe,pastorekovás,stuart-tilleyak,etal.interactionsoftransmembranecarbonicanhydrase,caix,withbicarbonatetransporters[j].amjphysiolcellphysiol,2007,293:c738-c748.
[25]  difiorea,desimoneg,menchisev,etal.carbonicanhydraseinhibitors:x-raycrystalstructureofabenzenesul-fonamidestrongcaⅱandcaixinhibitorbearingapenta-fluorophenylaminothioureidotailincomplexwithisozymeⅱ[j].bioorgmedchemlett,2005,15:1937-1942.
[26]  vullod,scozzafavaa,pastorekovas,etal.carbonicanhydraseinhibitors:inhibitionofthetumor-associatedisozymeixwithfluorine-containingsulfonamides.thefirstsubnanomolarcaixinhibitordiscovered[j].bioorgmedchemlett,2004,14:2351-2356.
[27]  riafrechale,rodríguezom,vullod,etal.synthesisofc-cinnamoylglycosidesandtheirinhibitoryactivityagainstmammaliancarbonicanhydrases[j].bioorgmedchem,2013,21:1489-1494.
[28]  winumjy,vullod,casinia,etal.carbonicanhydraseinhibitors.inhibitionofcytosolicisozymesiandⅱandtransmembrane,tumor-associatedisozymeixwithsulfamatesincludingematealsoactingassteroidsulfataseinhibitors[j].jmedchem,2003,46:2197-2204.
[29]  wilkinsonbl,bornaghilf,houstonta,etal.anovelclassofcarbonicanhydraseinhibitors:glycoconjugatebenzenesulfonamidespreparedby"click-tailing"[j].jmedchem,2006,49:6539-6548.
[30]  lopezm,trajkovicj,bornaghilf,etal.design,synthesis,andbiologicalevaluationofnovelcarbohydrate-basedsulfamatesascarbonicanhydraseinhibitors[j].jmedchem,2011,54:1481-1489.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133